The UNSW researchers analysed the performance of close to 11,000 PV modules. Image: Agata Bogucka, NREL. Up to one-fifth of solar PV modules degrade 1.5 times faster than average, according to new ...

A good night's sleep might be an additional benefit some gain from taking weight-loss drugs like Ozempic and Zepbound, a new study says. Obese patients with type 2 diabetes are less likely to need a ...

Italian energy agency Gestore dei servizi energetici (GSE) has announced the second solar energy auction under Italy's new incentive scheme for renewable energy, the transitional FER X program, ...

If you’re new to NYT Connections, here’s a quick way to get into the groove. Start by tackling the yellow group. It’s usually the easiest and helps you build momentum right away. And don’t sleep on ...

Uzbekistan aims to source 25% of its electricity from renewable energy by 2030. Credit: Kampan/Shutterstock.com. JA Solar has reached an agreement with Larsen & Toubro (L&T) to supply 1.2GW of ...

ROANOKE, Va. (WDBJ) - One billion people globally live with migraines. There have been advances in the world of migraines; however, migraine sufferers continue to bear the pain. Despite new ...

CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture junkie, is co-author of "Whatever Happened to Pudding Pops? The Lost Toys, Tastes and Trends of the '70s and '80s," as well as "The ...

The Trump administration is taking advantage of low oil prices and buying 1 million barrels to start refilling the nation’s depleted emergency crude supply. The Energy Department announced Tuesday ...

Weight-loss drugs like Ozempic and Zepbound might help protect people from health risks related to sleep apnea, a new study says. Type 2 diabetes patients taking GLP-1 drugs were overall less likely ...

Curious to solve the NYT Connections for September 1, 2025? Here’s the help you need. Yesterday’s game featured hints related to condemn, board games, heteronyms, and sticks. The clues seemed quite ...

Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 ...